z-logo
open-access-imgOpen Access
Anticoagulant-induced oral bleeding
Author(s) -
Victor Costa,
Estela Kaminagakura
Publication year - 2017
Publication title -
brazilian dental science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.153
H-Index - 6
ISSN - 2178-6011
DOI - 10.14295/bds.2017.v20i3.1379
Subject(s) - medicine , warfarin , atrial fibrillation , anticoagulant , thrombosis , lesion , pulmonary embolism , cardiology , stroke (engine) , deep vein , surgery , mechanical engineering , engineering
Warfarin is an anticoagulant used to prevent thrombosis, cardiac arrhythmias, atrial fibrillation, and recurrence of pulmonary embolism. A 69-year-old male patient reported episodes of four heart attacks, stroke, pulmonary emphysema, varicose veins, thyroid dysfunction, and a history of angioplasty. They use daily dose of 5 mg. Intraoral clinical examination revealed a bleeding nodular lesion of purple color with irregular borders and a smooth surface. The prothrombin time was 68.9 seconds, activity was 10%, and the international normalized ratio (INR) was 8.26. Based on these results, the patient received a single dose of 2.5 mg vitamin K via subcutaneous route. The final diagnosis was oral anticoagulant-induced lesions. Clinicians should be familiar with the side effects of anticoagulants, which are rare in the oral cavity, but can be life-threatening if diagnosed late or inaccurately, especially in older patients that often use many drugs.KeywordsAnticoagulant; Hemorrhage; Warfarin; Mouth.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom